Health Care Equipment & Services

Onemednet’s insider buying signals confidence in its low‑radiation imaging platform, backed by FDA and EMA approvals and a 30% faster diagnostic time.

MYOMO insider trades show strategic RSU‑based buying and tax‑planning selling, reinforcing long‑term alignment with shareholders amid growing medical‑robotics opportunities.

Insight into Hinge Health insider trading shows disciplined CFO moves amid a 6.9% weekly rally, reinforcing confidence in the digital PT company’s growth and valuation.

Elevance Health insiders are buying in: Marks Gilbert Lynn’s zero‑price stock grant shows confidence amid analyst‑raised targets and rising share price.

Insider buying by Integra LifeSciences’ C‑suite signals bullish confidence—yet the company’s negative P/E and modest gains urge careful evaluation before investing.

CEO Ben‑Noon Dagi Shahar’s recent QTREX Quantum share buys signal strong confidence, but the stock’s negative earnings and compliance hurdles keep a cautious eye on potential gains.

GIC’s recent Medline share sell‑off cuts its stake 25% yet keeps a core position—analyzing why the sovereign fund sees value in Medline’s tech‑enabled supply chain.

Investor insight: Nano‑X Imaging’s insider RSU grant fuels confidence as its AI‑driven imaging platform gains FDA clearance and expands pharma contracts—watch the 2026‑2027 milestones for upside potential.

New insider buying by Novel Inspiration shows IRIDEX is gaining confidence, with a disciplined build‑up to 700k shares amid a strong rally and low valuation.

Insider Koren Ofir’s RSU buy at Nano‑X signals confidence in its cloud imaging tech amid a steep 88% dip—why investors should watch the February vesting.